Viewing nowCombinationPitaaba Tablet (Pitavastatin, Fenofibrate)
Fenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Aprogen BioLogic Co., Ltd.

MFDS item code 202502259 · Approved 2025.08.28 · Insurance code 645211090
Treatment of mixed dyslipidemia in adults at high risk of coronary heart disease
This medication is used to appropriately control LDL cholesterol levels in adult patients at high risk for coronary artery disease and for the treatment of mixed dyslipidemia. It works effectively even when triglyceride levels are high and HDL cholesterol levels are low. This helps reduce the risk of cardiovascular diseases and maintain a healthy blood lipid profile. It aids in safe and effective management according to the patient's treatment goals.
The recommended dose is 1 tablet once daily, immediately after a meal.
This medication can affect the muscles, so if symptoms such as muscle pain, muscle weakness, or muscle cramps occur, consult a doctor immediately. Particular caution is required for the elderly, women, patients with poor kidney function, patients with uncontrolled hypothyroidism, patients with a history of muscle diseases, and patients with alcohol abuse. This medication may increase the risk of muscle damage when taken with other lipid-lowering agents or specific medications, so always consult a doctor regarding co-administration. Patients with poor liver function or liver disease, gallbladder disease, or pancreatitis should not use this medication. Patients with moderate to severe renal impairment should not be administered this drug, and those with mild renal impairment should use it cautiously. Women who are pregnant or may become pregnant, nursing mothers, and children under 18 years of age should not take this medication. Patients with blood coagulation disorders or those taking anticoagulants should exercise caution due to the risk of bleeding. Regular blood tests and liver function tests should be conducted during the treatment, and any abnormal symptoms should be reported to medical personnel immediately. Dizziness may occur when driving or operating machinery, so caution is advised. In case of overdose, there is no specific antidote, so appropriate treatment should be administered based on symptoms. It is advisable to take this medication with food, and store it in its original container out of the reach of children.
nasopharyngitis, upper respiratory infection, increased ALT, increased AST, increased GGT, abnormal liver function tests, gastroesophageal reflux disease, nausea, headache, dizziness, increased CPK, hypertension, chronic gastritis, erosive gastritis, decreased hemoglobin, decreased white blood cell count, decreased platelet count, decreased granulocyte count, decreased leukocyte count, increased eosinophils, increased leukocytes, elevated globulins, positive Coombs test, anemia, hypersensitivity, headache, fatigue, dizziness, stiffness, drowsiness, insomnia, heaviness, paralysis, thromboembolism, interstitial lung disease, gastrointestinal symptoms, pancreatitis, thirst, dyspepsia, abdominal pain, abdominal distension, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, increased transaminase, cholelithiasis, jaundice, complications of cholelithiasis, elevated bilirubin, increased cholinesterase, elevated AST, elevated ALT, increased γ-GT, elevated ALP, elevated LDH, decreased aldosterone, increased aldosterone, increased adrenocorticotropic hormone, increased cortisol, decreased testosterone, severe skin reaction, skin hypersensitivity, rash, itching, urticaria, alopecia, phototoxicity, muscle disorder, myalgia, myositis, muscle cramps, muscle weakness, renal failure, rhabdomyolysis, myopathy, muscle cramps, elevated myoglobin, increased CPK, weakness, increased urination, elevated BUN, increased serum creatinine, sexual dysfunction, increased serum homocysteine levels, increased hematuria, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photopsia, hearing loss, urinary hematuria, increased uric acid levels, increased serum potassium and phosphate levels, taste alteration, colored urine, lethargy, positive antinuclear antibodies, alopecia, thrombocytopenia, increased blood pressure, tingling skin, chest discomfort, insomnia, sleep disturbances, loss of appetite, asthenia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness over time.
White rectangular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Aprogen BioLogic Co., Ltd.
CombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
HLB Therapeutics Co., Ltd.
CombinationFenofibrate Micronized 160mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.